Semax vs Selank: An Overview
Semax and Selank are two synthetic neuropeptides often compared in the nootropic and neuro-research literature because they were developed within the same research tradition yet derive from completely different parent molecules. Understanding their distinct origins is the key to any meaningful comparison.
Semax is a heptapeptide based on a fragment of adrenocorticotropic hormone, specifically the ACTH (4-10) sequence, extended with a stabilizing Pro-Gly-Pro tail. Selank is a synthetic analog of tuftsin, a naturally occurring immunomodulatory tetrapeptide, similarly extended with a Pro-Gly-Pro motif for stability. So while both share a proline-rich stabilizing terminus, their core sequences trace back to different endogenous peptides with different associated pathways.
This article compares Semax (10mg) and Selank (10mg) strictly at the level of structural origin, mechanism, and research context. For research use only; not for human or animal consumption.
Recommended Products
Peptide Origins and Mechanisms
The central distinction lies in the parent molecule each peptide is derived from, which shapes the pathways researchers associate with them. Semax, as an ACTH-fragment analog, is studied in the context of melanocortin-related and neurotrophic-factor signaling in research models. Selank, as a tuftsin analog, is examined more in the context of neuroimmune modulation and regulatory neuropeptide systems. Both are studied for effects on central-nervous-system research endpoints, which is why they appear side by side.
| Attribute | Semax | Selank |
|---|---|---|
| Parent molecule | ACTH (4-10) fragment | Tuftsin (tetrapeptide) |
| Class | Melanocortin-derived neuropeptide | Tuftsin-derived neuropeptide |
| Structure | Heptapeptide + Pro-Gly-Pro | Tetrapeptide core + Pro-Gly-Pro |
| Research focus | Neurotrophic, melanocortin pathways | Neuroimmune, regulatory pathways |
| Shared feature | Pro-Gly-Pro stabilizing tail | Pro-Gly-Pro stabilizing tail |
Because the two derive from different endogenous peptides, they are typically used to probe different research questions rather than as substitutes. A study of melanocortin-related neuropeptide signaling would reference Semax; a study of tuftsin-analog neuroregulation would reference Selank. Investigators building a broader neuropeptide panel sometimes add DSIP (10mg), delta sleep-inducing peptide, to include a structurally unrelated regulatory neuropeptide for contrast. Their shared Pro-Gly-Pro terminus gives both a degree of enzymatic stability, but their core sequences, molecular weights, and handling remain distinct. For the wider framework, see the pillar overview on nootropic and neuro research peptides explained.
Selecting Neuropeptides for Research
Researchers choose between Semax and Selank according to the neuropeptide system under study. When the research question concerns melanocortin-derived or neurotrophic signaling, Semax is the relevant reference. When it concerns tuftsin-analog or neuroimmune regulation, Selank is more appropriate. Comparative neuro-research designs use both, and sometimes DSIP, to span structurally distinct regulatory neuropeptides within a single panel.
Handling follows standard laboratory practice for lyophilized peptides: reconstitution with an appropriate sterile diluent, cold storage, protection from light, and minimized freeze-thaw cycling. Although Semax and Selank share a stabilizing terminus, their different core sequences give them different molecular weights, so reconstitution calculations should be performed per compound. Record lot numbers and preparation details to support reproducibility across experiments. Review Semax (10mg) and Selank (10mg) specifications before designing a comparative study. For research use only.